A PwC report finds that women’s health is evolving into a much larger, high-growth market as investment expands beyond reproductive care, though it remains underfunded and under-researched.
Nearly 40,000 people have signed a petition from the Alliance for Women’s Health and Prevention’s EveryBODY Covered Campaign urging employers to recognize obesity as a chronic condition and expand comprehensive coverage.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
Insurers are cutting coverage for costly GLP-1 weight loss drugs, sparking backlash from advocates who say they're vital for treating obesity.
The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under Medicare and Medicaid, which has disappointed some healthcare leaders.
The Alliance for Women’s Health and Prevention and several other organizations are urging employers to cover the "full range of evidence-based obesity care options," including medical nutrition therapy, intensive behavioral therapy, surgery and medications.
In this episode, we’re joined by Millicent Gorham, CEO of the Alliance for Women’s Health and Prevention (AWHP). AWHP recently launched the EveryBODY Covered campaign, which is advocating for comprehensive coverage of obesity care. Gorham discusses the current state of obesity treatment for women and her goals for the campaign.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!